The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
119495748 11949574 8 F 20140616 20160928 20160125 20160930 EXP PHHY2016DE008834 NOVARTIS 0.00 E F Y 73.00000 KG 20160930 OT DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
119495748 11949574 1 PS AFINITOR EVEROLIMUS 1 Oral 10 MG, QD D 22334 10 MG TABLET QD
119495748 11949574 2 SS AFINITOR EVEROLIMUS 1 Oral 10 MG, QD D 22334 10 MG TABLET QD
119495748 11949574 3 SS AFINITOR EVEROLIMUS 1 Oral 05 MG, QD D 22334 5 MG TABLET QD
119495748 11949574 4 SS AFINITOR EVEROLIMUS 1 Oral 05 MG, QD D 22334 5 MG TABLET QD
119495748 11949574 5 SS CAELYX DOXORUBICIN HYDROCHLORIDE 1 Unknown 65 MG, QD D 0 65 MG QD
119495748 11949574 6 C EXEMESTANE. EXEMESTANE 1 Oral 25 MG, QD D 0 25 MG QD
119495748 11949574 7 C METOBETA 2 Oral 100 MG, QD D 0 100 MG QD
119495748 11949574 8 C RAMIPRIL. RAMIPRIL 1 Oral 5 MG, QD D 0 5 MG QD
119495748 11949574 9 C VOLTAREN DICLOFENAC SODIUM 1 Unknown UNK UNK, QD D 0 QD
119495748 11949574 10 C PANTOZOL PANTOPRAZOLE SODIUM 1 Unknown 40 MG, QD D 0 40 MG QD
119495748 11949574 11 C FOLICOMBIN 2 Unknown UNK UNK, QD D 0 QD
119495748 11949574 12 C METFORMIN METFORMIN HYDROCHLORIDE 1 Oral UNK UNK, QD (ACCORDING TO BLOOD SUGAR) D 0 QD
119495748 11949574 13 C DUROGESIC FENTANYL 1 Oral 100 UG, UNK (EVERY 3 DAYS) D 0 100 UG
119495748 11949574 14 C XGEVA DENOSUMAB 1 Unknown 120 MG, QMO D 0 120 MG /month

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
119495748 11949574 1 Breast cancer metastatic
119495748 11949574 5 Product used for unknown indication
119495748 11949574 6 Breast cancer metastatic
119495748 11949574 7 Hypertension
119495748 11949574 8 Hypertension
119495748 11949574 9 Product used for unknown indication
119495748 11949574 10 Product used for unknown indication
119495748 11949574 11 Product used for unknown indication
119495748 11949574 12 Diabetes mellitus
119495748 11949574 13 Product used for unknown indication
119495748 11949574 14 Metastases to bone

Outcome of event

Event ID CASEID OUTC COD
119495748 11949574 OT
119495748 11949574 LT
119495748 11949574 HO
119495748 11949574 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
119495748 11949574 Aortic arteriosclerosis
119495748 11949574 Aortic calcification
119495748 11949574 Aortic dilatation
119495748 11949574 Aortic valve disease
119495748 11949574 Aortic valve incompetence
119495748 11949574 Aortic valve stenosis
119495748 11949574 Atrial fibrillation
119495748 11949574 Atrial flutter
119495748 11949574 Biliary dilatation
119495748 11949574 Bladder mass
119495748 11949574 C-reactive protein increased
119495748 11949574 Cardiac failure
119495748 11949574 Cardiac murmur
119495748 11949574 Carotid arteriosclerosis
119495748 11949574 Degenerative mitral valve disease
119495748 11949574 Dyspnoea exertional
119495748 11949574 Faecaloma
119495748 11949574 Fatigue
119495748 11949574 Gamma-glutamyltransferase increased
119495748 11949574 General physical health deterioration
119495748 11949574 Haemoglobin decreased
119495748 11949574 Hepatomegaly
119495748 11949574 Klebsiella test positive
119495748 11949574 Left atrial enlargement
119495748 11949574 Left ventricular dysfunction
119495748 11949574 Left ventricular hypertrophy
119495748 11949574 Malignant neoplasm progression
119495748 11949574 Mitral valve calcification
119495748 11949574 Mitral valve incompetence
119495748 11949574 Nausea
119495748 11949574 Nephrocalcinosis
119495748 11949574 Oedema peripheral
119495748 11949574 Palpitations
119495748 11949574 Pancreatic atrophy
119495748 11949574 Pancreatic steatosis
119495748 11949574 Pleural effusion
119495748 11949574 Pulmonary congestion
119495748 11949574 Toxicity to various agents
119495748 11949574 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
119495748 11949574 1 20130903 20130912 0
119495748 11949574 2 20130919 20130920 0
119495748 11949574 3 20131002 20131223 0
119495748 11949574 4 20140107 20140730 0
119495748 11949574 5 20151022 20151022 0
119495748 11949574 6 20130903 20140730 0
119495748 11949574 7 201307 0
119495748 11949574 8 201307 0
119495748 11949574 9 201307 0
119495748 11949574 10 201307 0
119495748 11949574 11 201307 0
119495748 11949574 12 201307 0
119495748 11949574 13 201307 0
119495748 11949574 14 20130903 20131104 0